Hologic Secures Significant Patent Victory Against Siemens Over Breast Cancer Detection Technology

Contributed by: Business Wire

Logo

Tags

Biotechnology

FDA

Professional Services

Health

General Health

Women

Pharmaceutical

Oncology

Legal

Consumer

Clinical Trials

Hologic, Inc.

More Like This

Hologic to Unveil Groundbreaking AI Research at ECR 2024

PR Newswire associated0

New technology aiming to improve patients' outcomes in breast cancer

Hologic Obtains CE Mark for Affirm® Contrast Biopsy Software

Hologic to Acquire Endomagnetics Ltd, a Breast Surgical Guidance Company

PR Newswire associated0

Sirius Medical collaborates with GE Healthcare to showcase the Pintuition® and CEM combination for an efficient and accurate breast cancer care pathway

United Imaging Strengthens Presence in Europe with Comprehensive Innovation Portfolio at ECR 2026

At Varian, a Siemens Healthineers company, we envision a world without fear of cancer. For more than 75 years, Varian has developed, built, and delivered innovative technologies and solutions that help care providers around the globe treat millions of patients each year. Today, as a Siemens Healthineers company, we support every step of the cancer care journey – from screening to survivorship. From advanced imaging and radiation therapy to comprehensive software and services, to interventional radiology, we are harnessing the power of our perspective while also pursuing clinical research to create a more efficient, and more personalized care pathway. Because, for cancer patients everywhere, their fight is our fight.

More Impact, Together: Varian and Siemens Healthineers Portfolios Highlight More Impact, Innovations and More Breakthroughs Throughout Cancer Care Journey at ESTRO 2025

PR Newswire associated0

United Imaging Showcases Advanced Molecular Imaging Innovations and Highlights European Growth at EANM 2025